You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Drug Price Trends for HYDROCORTISONE-ALOE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HYDROCORTISONE-ALOE

Average Pharmacy Cost for HYDROCORTISONE-ALOE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HYDROCORTISONE-ALOE 1% CREAM 51672-5330-01 0.12898 GM 2026-03-18
HYDROCORTISONE-ALOE 1% CREAM 00536-1407-95 0.05368 GM 2026-03-18
HYDROCORTISONE-ALOE 1% CREAM 51672-2013-01 0.12898 GM 2026-03-18
HYDROCORTISONE-ALOE 1% CREAM 51672-2013-02 0.07247 GM 2026-03-18
HYDROCORTISONE-ALOE 1% CREAM 51672-5330-02 0.07247 GM 2026-03-18
HYDROCORTISONE-ALOE 1% CREAM 70000-0662-01 0.05368 GM 2026-03-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

HYDROCORTISONE-ALOE Market Analysis and Financial Projection

Last updated: February 14, 2026

Market Analysis and Price Projections for Hydrocortisone-Aloe

Overview

Hydrocortisone-Aloe combines a topical corticosteroid with aloe vera, often marketed for skin inflammation and irritation. Its patent status, regulatory approval, competitive landscape, and manufacturing costs influence pricing and market potential.

Market Size and Growth

The global dermatological market was valued at approximately $18.7 billion in 2021, with corticosteroids representing a significant segment. The demand for topical anti-inflammatory formulations remains strong, driven by rising incidences of dermatitis, eczema, and psoriasis.

The segment for combination products with natural ingredients like aloe vera is expanding. Aloe vera’s soothing properties favor niche markets emphasizing natural or herbal components, fueling the growth of Hydrocortisone-Aloe formulations.

Patent Status and Regulatory Factors

Most Hydrocortisone formulations are off-patent, affecting pricing power. However, the incorporation of aloe vera as a proprietary extract or formulation element may afford regulatory exclusivity if protected as a novel ingredient or delivery system.

Regulatory approvals from agencies such as the FDA or EMA are typically fast for well-known active ingredients like hydrocortisone but depend on formulation specifics. Patent protections concerning proprietary extracts or formulations can extend exclusivity periods, impacting pricing.

Competitive Landscape

Major competitors include generic hydrocortisone brands and herbal topical products. Key players include:

  • Mylan and Teva (generics)
  • Aveeno (aloe-based skincare)
  • Chattem (herbal formulations)

No significant premium pricing exists for aloe-based combination products in the current market; they tend to command a slight premium over generic hydrocortisone due to perceived natural safety profiles.

Pricing Trends and Projections

Current Pricing (US Retail):

  • Generic hydrocortisone 1% cream: $2–$4 per 15g tube
  • Aloe-infused hydrocortisone formulations: Typically $4–$8 per 15g tube, reflecting branding and natural ingredient premium

Projected Pricing (Next 3–5 Years):

Scenario Price Range (per 15g tube) Key Drivers
Standard generic expansion $2–$4 Price erosion due to generic competition
Brand differentiation $6–$10 Proprietary aloe extract, patent protection
Natural/Herbal niche $8–$15 Growing consumer preference for natural products

Price premiums for aloe-infused formulations are expected to stabilise around 20–50% over generic hydrocortisone, assuming no significant patent extensions or exclusive formulations.

Distribution Channels

Pharmacies and drugstores dominate sales, but online direct-to-consumer channels grow rapidly, especially for natural skincare products. OTC classification accelerates adoption, with dermatologists prescribing or recommending where applicable.

Regulatory and Market Entry Barriers

Patents on the combination formulation could delay generic entry. However, if no patent rights exist, market entry becomes easier but limits pricing flexibility. The key barrier is creating a proprietary aloe extract or formulation that qualifies for patent protection.

Key Considerations for Investment and R&D

  • Developing a patentable aloe formulation increases pricing potential.
  • Targeting dermatology clinics and natural product markets expands market access.
  • Collaborations with herbal ingredient suppliers can ensure consistent quality and supply.

Key Takeaways

  • The total market for corticosteroid-based topical treatments is mature, with slow growth primarily driven by natural ingredient blends.
  • Prices for Hydrocortisone-Aloe products are likely to remain stable short-term, with potential increases if patent protection is secured.
  • Competitive pricing will pressure margins; differentiation through formulation or branding is necessary for premium positioning.
  • Regulatory exclusivity plays a critical role but is limited without patent protections.
  • Distribution trends favor direct-to-consumer online sales of natural or herbal products.

FAQs

1. What factors influence the pricing of Hydrocortisone-Aloe products?

Patent status, formulation complexity, branding, natural ingredient premium, and regulatory exclusivity determine pricing.

2. Will Hydrocortisone-Aloe formulations replace standard hydrocortisone products?

Unlikely; they function as niche products appealing to consumers seeking natural ingredients. Price and efficacy will weigh heavily in consumer choice.

3. How does patent protection impact market entry?

Patent protection delays generic entry, allowing for higher pricing. Without patents, generic competitors will suppress prices.

4. What is the market growth outlook for natural ingredient topical products?

Moderate; these products benefit from increasing consumer preference for natural and herbal ingredients but face stiff competition and regulatory complexities.

5. How can developers extend product exclusivity?

By securing patents on unique formulations, delivery mechanisms, or proprietary aloe extracts, companies can extend exclusivity periods.


References

  1. MarketWatch, "Dermatology Drugs Market Size," 2022.
  2. IQVIA, "Topical corticosteroids Market Analysis," 2021.
  3. FDA, "Drug Patent and Exclusivity Data," 2022.
  4. Grand View Research, "Herbal and Natural Skin Care Market," 2022.
  5. Statista, "Global OTC Market," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.